SPATS2 and hepatocellular carcinoma: Next, the above findings were consistent with our own cohort, which confirmed that high SPATS2 protein level is indicative of an unfavorable clinicopathological feature and poor prognosis and could serve as an independent risk factor for both OS and DFS of 112 HCC patients.